Rezvani A
INSERM U.351, Institut Gustave-Roussy, Villejuif.
Ann Urol (Paris). 1992;26(5):266-74.
In 1989, 14,150 men died from urological cancer in France: 64% of these deaths were due to prostatic cancer, which represents the second highest cause of male cancer mortality in France. Deaths from urological cancer are mainly observed after 50 years of age, with a frequency which increases very rapidly with age, except for testicular cancer for which one out of every two deaths occurs between 20 and 45 years of age. Between 1968 and 1989, increased mortality was observed in males due to prostate cancer and kidney cancers, whereas a decreased mortality was observed for testicular cancer, especially in males between 20 and 45 years of age. Mortality was stable for bladder cancer and cancer of the penis. In females during the same period, mortality was stable for cancer of the kidney and bladder. During the period 1979 to 1984, a significant increase in mortality due to bladder cancer was observed in certain Northern departments and those surrounding the Mediterranean basin, although the mortality for other cancer sites is generally lower in this latter region. A significant increase in mortality was also observed for cancer of the kidney in Auvergne and in Alsace-Lorraine. Regarding prostatic cancer, geographical variations are minor and no particular region with an increased or decreased mortality could be identified.
1989年，法国有14,150名男性死于泌尿系统癌症：其中64%的死亡归因于前列腺癌，前列腺癌是法国男性癌症死亡的第二大原因。泌尿系统癌症死亡主要发生在50岁之后，且随着年龄增长频率迅速上升，但睾丸癌除外，每两例睾丸癌死亡病例中有一例发生在20至45岁之间。1968年至1989年期间，观察到男性因前列腺癌和肾癌导致的死亡率上升，而睾丸癌死亡率下降，尤其是20至45岁的男性。膀胱癌和阴茎癌的死亡率保持稳定。同一时期，女性肾癌和膀胱癌的死亡率保持稳定。在1979年至1984年期间，在某些北部省份以及地中海盆地周边地区，观察到膀胱癌导致的死亡率显著上升，尽管后一地区其他癌症部位的死亡率普遍较低。奥弗涅地区和阿尔萨斯 - 洛林地区的肾癌死亡率也显著上升。关于前列腺癌，地域差异较小，无法确定死亡率上升或下降的特定地区。
